<b>Background</b>: Deletion of the <i>MTAP</i> gene at chromosome 9p21.3 defines a therapeutically actionable molecular subset of cancers due to synthetic lethal vulnerability to PRMT5 and MAT2A inhibition. This evidence concerns the gene MTAP and cancer.